scholarly journals Prolonged methylene blue infusion in refractory septic shock: a case report

2011 ◽  
Vol 58 (4) ◽  
pp. 401-405 ◽  
Author(s):  
Tristan C. Dumbarton ◽  
Samuel Minor ◽  
Colin K. Yeung ◽  
Robert Green
CHEST Journal ◽  
2020 ◽  
Vol 158 (4) ◽  
pp. A2558
Author(s):  
Mouhanned Eliliwi ◽  
Jennifer Meyfeldt ◽  
Stephanie Hart ◽  
Eliot Friedman

2016 ◽  
Vol 44 (12) ◽  
pp. 573-573
Author(s):  
Cyril Varghese ◽  
Erin Demartino ◽  
Egan Ashley ◽  
Jaclyn Jacobi ◽  
Daniels Lisa ◽  
...  

2021 ◽  
Vol 22 (Supplement 1 3S) ◽  
pp. 297-297
Author(s):  
J. Rodriguez Coronado ◽  
J. Saldivar Martinez ◽  
R. Gomez Gutierrez ◽  
G. Quezada Valenzuela ◽  
M. Contreras Cepeda ◽  
...  

2021 ◽  
Vol 22 (Supplement 1 3S) ◽  
pp. 132-133
Author(s):  
C.D. Hernandez Rosales ◽  
A. Rodriguez Sanchez ◽  
J. Rodriguez Coronado ◽  
R. Gomez Gutierrez ◽  
B. Cardenas Del Castillo

2021 ◽  
Vol 18 (3) ◽  
pp. 79-86
Author(s):  
L. L. Plotkin

Refractory shock is the shock that does not respond to vasopressor therapy. Refractory shock with a short-term mortality rate of more than 50% is diagnosed in 6-7% of critically ill patients. There is an objective need to Investigate methods of intensive therapy for refractory septic shock.The objective of the study: to analyze literature data on the intensive care of refractory septic shock.Results. The second part of the article analyzes 37 studies, both Russian and foreign ones devoted to the intensive care of refractory shock. At present, based on the analysis of the publication, it is impossible to draw reasonable conclusions about the advantage of one or another method of intensive therapy for refractory shock (veno-venous hemofiltration, the use of angiotensin II and vasopressin, as well as methylene blue, vitamin B12, ECMO) over basic therapy.


2005 ◽  
Vol 20 (2) ◽  
pp. 123 ◽  
Author(s):  
Byung-Kyu Park ◽  
Tae-Sun Shim ◽  
Chae-Man Lim ◽  
Sang-Do Lee ◽  
Woo-Sung Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document